158 related articles for article (PubMed ID: 9321761)
1. Uptake of genetic testing for cancer predisposition.
Evans DG; Maher ER; Macleod R; Davies DR; Craufurd D
J Med Genet; 1997 Sep; 34(9):746-8. PubMed ID: 9321761
[TBL] [Abstract][Full Text] [Related]
2. Childhood predictive genetic testing for Li-Fraumeni syndrome.
Evans DG; Lunt P; Clancy T; Eeles R
Fam Cancer; 2010 Mar; 9(1):65-9. PubMed ID: 19404774
[TBL] [Abstract][Full Text] [Related]
3. Genetic testing for cancer predisposition.
Eng C; Hampel H; de la Chapelle A
Annu Rev Med; 2001; 52():371-400. PubMed ID: 11160785
[TBL] [Abstract][Full Text] [Related]
4. Parent decision-making around the genetic testing of children for germline TP53 mutations.
Alderfer MA; Zelley K; Lindell RB; Novokmet A; Mai PL; Garber JE; Nathan D; Scollon S; Chun NM; Patenaude AF; Ford JM; Plon SE; Schiffman JD; Diller LR; Savage SA; Malkin D; Ford CA; Nichols KE
Cancer; 2015 Jan; 121(2):286-93. PubMed ID: 25223899
[TBL] [Abstract][Full Text] [Related]
5. Hereditary gastrointestinal cancer.
Hata K; Yamamoto Y; Kiyomatsu T; Tanaka T; Kazama S; Nozawa H; Kawai K; Tanaka J; Nishikawa T; Otani K; Yasuda K; Kishikawa J; Nagai Y; Anzai H; Shinagawa T; Arakawa K; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Watanabe T
Surg Today; 2016 Oct; 46(10):1115-22. PubMed ID: 26676416
[TBL] [Abstract][Full Text] [Related]
6. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service.
Evans DG; Howard E; Giblin C; Clancy T; Spencer H; Huson SM; Lalloo F
Am J Med Genet A; 2010 Feb; 152A(2):327-32. PubMed ID: 20082463
[TBL] [Abstract][Full Text] [Related]
7. Endocrine tumors associated with neurofibromatosis type 1, Peutz-Jeghers syndrome and other familial neoplasia syndromes.
Kalkan E; Waguespack SG
Front Horm Res; 2013; 41():166-81. PubMed ID: 23652677
[TBL] [Abstract][Full Text] [Related]
8. Familial neurogenic tumor syndromes.
Kimmelman A; Liang BC
Hematol Oncol Clin North Am; 2001 Dec; 15(6):1073-84. PubMed ID: 11770299
[TBL] [Abstract][Full Text] [Related]
9. Genetic basis of tumour development.
Ponz de Leon M
Ital J Gastroenterol; 1996 May; 28(4):232-45. PubMed ID: 8842841
[TBL] [Abstract][Full Text] [Related]
10. Evaluation after five years of the cancer genetic counselling programme of Valencian Community (Eastern Spain).
Cuevas-Cuerda D; Salas-Trejo D
Fam Cancer; 2014 Jun; 13(2):301-9. PubMed ID: 24242329
[TBL] [Abstract][Full Text] [Related]
11. Preimplantation genetic diagnosis for cancer predisposition.
Rechitsky S; Verlinsky O; Chistokhina A; Sharapova T; Ozen S; Masciangelo C; Kuliev A; Verlinsky Y
Reprod Biomed Online; 2002; 5(2):148-55. PubMed ID: 12419039
[TBL] [Abstract][Full Text] [Related]
12. Familial cancer syndromes and genetic counseling.
Tomlinson GE
Cancer Treat Res; 1997; 92():63-97. PubMed ID: 9494758
[No Abstract] [Full Text] [Related]
13. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.
Gläsker S; Bender BU; Apel TW; Natt E; van Velthoven V; Scheremet R; Zentner J; Neumann HP
J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):758-62. PubMed ID: 10567493
[TBL] [Abstract][Full Text] [Related]
14. Targeted therapy for hereditary cancer syndromes: hereditary breast and ovarian cancer syndrome, Lynch syndrome, familial adenomatous polyposis, and Li-Fraumeni syndrome.
Agarwal R; Liebe S; Turski ML; Vidwans SJ; Janku F; Garrido-Laguna I; Munoz J; Schwab R; Rodon J; Kurzrock R; Subbiah V;
Discov Med; 2014 Dec; 18(101):331-9. PubMed ID: 25549704
[TBL] [Abstract][Full Text] [Related]
15. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis.
Giardiello FM; Brensinger JD; Petersen GM; Luce MC; Hylind LM; Bacon JA; Booker SV; Parker RD; Hamilton SR
N Engl J Med; 1997 Mar; 336(12):823-7. PubMed ID: 9062090
[TBL] [Abstract][Full Text] [Related]
16. Imaging of cancer predisposition syndromes in children.
Monsalve J; Kapur J; Malkin D; Babyn PS
Radiographics; 2011; 31(1):263-80. PubMed ID: 21257945
[TBL] [Abstract][Full Text] [Related]
17. Ethical issues: the geneticist's view point.
Evans G
Dis Markers; 1992; 10(4):199-203; discussion 211-28. PubMed ID: 1338981
[No Abstract] [Full Text] [Related]
18. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ
J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
[TBL] [Abstract][Full Text] [Related]
19. Genetic causes of brain tumors: neurofibromatosis, tuberous sclerosis, von Hippel-Lindau, and other syndromes.
Farrell CJ; Plotkin SR
Neurol Clin; 2007 Nov; 25(4):925-46, viii. PubMed ID: 17964021
[TBL] [Abstract][Full Text] [Related]
20. Does germ-line deletion of the PIP gene constitute a widespread risk for cancer?
Silva AG; Krepischi AC; Torrezan GT; Capelli LP; Carraro DM; D'Angelo CS; Koiffmann CP; Zatz M; Naslavsky MS; Masotti C; Otto PA; Achatz MI; Mills RE; Lee C; Pearson PL; Rosenberg C
Eur J Hum Genet; 2014 Mar; 22(3):307-9. PubMed ID: 23778870
[No Abstract] [Full Text] [Related]
[Next] [New Search]
